Giacomo Buso: Complex and Fragile Management of Patients with Vascular Ehlers-Danlos Syndrome
Giacomo Buso, Internal Medicine Physician, Angiologist FMH at Spedali Civili Hospital, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Some papers matter more than others. This one does.
Not only because it deals with the complex and fragile management of patients with vascular Ehlers-Danlos syndrome (vEDS), but because of the people behind it.
This work, published on EJCRIM | European Journal of Case Reports in Internal Medicine was developed together with young, motivated medical talents from the State of Palestine, and I am genuinely proud of their commitment, curiosity, and clinical insight throughout the process.
vEDS reminds us daily that medicine is not about protocols alone.
It is about balance, experience, teamwork, and sometimes choosing not to intervene.
Misdiagnosis, inappropriate procedures, or interruption of therapy can have dramatic consequences.
Awareness truly saves lives.
Seeing this article recently cited by QS pro is meaningful, but what matters most to me is the message behind it:
- rare diseases need culture
- complexity needs shared knowledge
- young physicians need opportunities, trust, and mentorship
Spreading awareness about vEDS means protecting patients.
Working with these young colleagues means investing in the future of medicine, even, and especially, in difficult clinical contexts.”
Title: Challenges in the Management of Patients with Vascular Ehlers-Danlos Syndrome: Lessons from three Clinical Cases
Authors: Lara Alayasa, Razan Fiala, Adriana Skafi, Tala Sulaiman, Matteo Lemoli, Giacomo Buso, Maria Lorenza Muiesan
Read the Full Article on European Journal of Case Reports in Internal Medicine/PubMed Central

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines